Asian Penny Stocks To Watch In April 2026

As global markets react positively to signs of de-escalation in the Middle East, Asian markets are also experiencing a wave of optimism. This backdrop provides an intriguing setting for investors exploring penny stocks, a term that, while somewhat antiquated, still captures the potential of smaller or newer companies offering value at lower price points. By focusing on those with strong financials and clear growth trajectories, investors may uncover opportunities among these often-overlooked stocks that could offer both stability and upside potential.

Top 10 Penny Stocks In Asia

Name	Share Price	Market Cap	Rewards & Risks
Guoquan Food (Shanghai) (SEHK:2517)	HK$3.10	HK$8.15B	✅ 5 ⚠️ 1 View Analysis >
Yonghe Medical Group (SEHK:2279)	HK$2.06	HK$1.03B	✅ 4 ⚠️ 1 View Analysis >
Lever Style (SEHK:1346)	HK$1.46	HK$904.98M	✅ 3 ⚠️ 1 View Analysis >
Natural Food International Holding (SEHK:1837)	HK$1.74	HK$3.81B	✅ 4 ⚠️ 1 View Analysis >
North East Rubber (SET:NER)	THB4.88	THB9.02B	✅ 5 ⚠️ 2 View Analysis >
YesAsia Holdings (SEHK:2209)	HK$3.35	HK$1.4B	✅ 4 ⚠️ 2 View Analysis >
PC Partner Group (SGX:PCT)	SGD1.70	SGD659.4M	✅ 4 ⚠️ 2 View Analysis >
CNMC Goldmine Holdings (Catalist:5TP)	SGD1.45	SGD587.67M	✅ 4 ⚠️ 2 View Analysis >
Yangzijiang Shipbuilding (Holdings) (SGX:BS6)	SGD4.09	SGD16.1B	✅ 4 ⚠️ 2 View Analysis >
Bosideng International Holdings (SEHK:3998)	HK$4.17	HK$48.47B	✅ 4 ⚠️ 2 View Analysis >

Click here to see the full list of 927 stocks from our Asian Penny Stocks screener.

Let's dive into some prime choices out of the screener.

Perfect Medical Health Management (SEHK:1830)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Perfect Medical Health Management Limited is an investment holding company that provides medical, aesthetic medical, and beauty and wellness services across Hong Kong, the People’s Republic of China, Macau, Australia, and Singapore with a market cap of approximately HK$1.57 billion.

Operations: The company generates revenue of HK$993.47 million from its services in medical, aesthetic medical, and beauty and wellness sectors.

Market Cap: HK$1.57B

Perfect Medical Health Management Limited, with a market cap of approximately HK$1.57 billion and revenue of HK$993.47 million, operates without debt, ensuring financial stability but faces challenges with declining earnings at 5.6% annually over five years and a recent negative growth of 44.6%. The company boasts high-quality earnings and a strong Return on Equity at 39.2%, yet its dividend yield of 10.32% is not well covered by earnings. Despite trading below fair value, its net profit margins have decreased from the previous year, indicating potential concerns for investors in this volatile penny stock space in Asia.

• Get an in-depth perspective on Perfect Medical Health Management's performance by reading our balance sheet health report here.
• Assess Perfect Medical Health Management's previous results with our detailed historical performance reports.

7Road Holdings (SEHK:797)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: 7Road Holdings Limited is an investment holding company that develops and distributes web and mobile games in the People’s Republic of China and internationally, with a market cap of HK$2.06 billion.

Operations: The company generates revenue of CN¥521.29 million from its computer graphics segment.

Market Cap: HK$2.06B

7Road Holdings, with a market cap of HK$2.06 billion, has recently turned profitable, reporting a net income of CN¥37.02 million for 2025 compared to a loss the previous year. The company benefits from being debt-free and has robust short-term assets exceeding liabilities significantly. However, earnings have declined by 41.2% annually over five years, and recent profits were affected by large one-off items totaling CN¥47.5 million. Despite volatility in its share price, the initiation of a share repurchase program could enhance shareholder value by increasing net asset value and earnings per share.

• Dive into the specifics of 7Road Holdings here with our thorough balance sheet health report.
• Gain insights into 7Road Holdings' historical outcomes by reviewing our past performance report.

17LIVE Group (SGX:LVR)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: 17LIVE Group Limited operates live streaming platforms across Japan, Taiwan, Hong Kong, and other parts of Asia with a market capitalization of SGD159.32 million.

Operations: 17LIVE Group Limited has not reported any specific revenue segments.

Market Cap: SGD159.32M

17LIVE Group Limited, with a market cap of SGD159.32 million, operates in the live streaming sector across Asia and reported sales of US$158.8 million for 2025 despite a net loss of US$0.924 million. The company remains unprofitable but has significantly reduced losses over five years and maintains a strong cash position, exceeding both short-term and long-term liabilities. Recent board changes include appointing Tay Eng Hoe as an Independent Director, potentially strengthening governance. While earnings are forecast to grow substantially by 81.97% annually, the dividend yield is not well covered by current earnings due to ongoing profitability challenges.

• Take a closer look at 17LIVE Group's potential here in our financial health report.
• Examine 17LIVE Group's earnings growth report to understand how analysts expect it to perform.

Seize The Opportunity

• Unlock our comprehensive list of 927 Asian Penny Stocks by clicking here.
• Ready For A Different Approach? Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com